As of 2025-07-03, the Relative Valuation of United Therapeutics Corp (UTHR) is 387.22 USD. This relative valuation is based on P/E multiples. With the latest stock price at 295.22 USD, the upside of United Therapeutics Corp based on Relative Valuation is 31.2%.
The range of the Relative Valuation is 365.01 - 422.45 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.6x - 13.7x | 13.6x |
| Forward P/E multiples | 13.7x - 14.7x | 14.2x |
| Fair Price | 365.01 - 422.45 | 387.22 |
| Upside | 23.6% - 43.1% | 31.2% |
| Date | P/E |
| 2025-07-02 | 11.00 |
| 2025-07-01 | 10.84 |
| 2025-06-30 | 10.71 |
| 2025-06-27 | 10.59 |
| 2025-06-26 | 10.59 |
| 2025-06-25 | 10.66 |
| 2025-06-24 | 10.80 |
| 2025-06-23 | 10.67 |
| 2025-06-20 | 10.83 |
| 2025-06-18 | 10.87 |
| 2025-06-17 | 10.69 |
| 2025-06-16 | 10.75 |
| 2025-06-13 | 10.56 |
| 2025-06-12 | 10.66 |
| 2025-06-11 | 10.30 |
| 2025-06-10 | 10.48 |
| 2025-06-09 | 12.24 |
| 2025-06-06 | 12.14 |
| 2025-06-05 | 11.91 |
| 2025-06-04 | 12.07 |
| 2025-06-03 | 12.08 |
| 2025-06-02 | 12.13 |
| 2025-05-30 | 11.88 |
| 2025-05-29 | 11.94 |
| 2025-05-28 | 11.76 |
| 2025-05-27 | 11.73 |
| 2025-05-23 | 11.46 |
| 2025-05-22 | 11.50 |
| 2025-05-21 | 11.54 |
| 2025-05-20 | 11.53 |
| 2025-05-19 | 11.38 |
| 2025-05-16 | 11.38 |
| 2025-05-15 | 11.32 |
| 2025-05-14 | 11.17 |
| 2025-05-13 | 11.48 |
| 2025-05-12 | 11.58 |
| 2025-05-09 | 11.23 |
| 2025-05-08 | 11.48 |
| 2025-05-07 | 11.44 |
| 2025-05-06 | 10.99 |
| 2025-05-05 | 11.13 |
| 2025-05-02 | 10.98 |
| 2025-05-01 | 10.95 |
| 2025-04-30 | 11.29 |
| 2025-04-29 | 11.21 |
| 2025-04-28 | 11.07 |
| 2025-04-25 | 10.86 |
| 2025-04-24 | 11.04 |
| 2025-04-23 | 10.93 |
| 2025-04-22 | 10.91 |